Lykopoulos, K., Collins, P., Hall, M., Ehness, R., Barth, J., & Louahed, J. (2014). P25. Access to diagnostics: A bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic. BioMed Central.
Citação norma ChicagoLykopoulos, K., P. Collins, M. Hall, R. Ehness, J. Barth, and J. Louahed. P25. Access to Diagnostics: A Bottleneck for Immunotherapeutics Development - Case Example of MAGE-A3 Cancer Immunotherapeutic. BioMed Central, 2014.
Citação norma MLALykopoulos, K., et al. P25. Access to Diagnostics: A Bottleneck for Immunotherapeutics Development - Case Example of MAGE-A3 Cancer Immunotherapeutic. BioMed Central, 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.